A Review of Cilostazol, a Phosphodiesterase Inhibitor, and its Role in Preventing Both Coronary and Peripheral Arterial Restenosis Following Endovascular Therapy

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|4|1|6-14

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.4, Iss.1, 2009-01, pp. : 6-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Femoral Artery Ultrasound Measurements in Predicting Restenosis Following Endovascular Intervention

By Wang Grace J.   Shaw Pamela A.   Mohler Emile R.   Durinka Joel B.   Layne Andrew J.   Etherington Mark S.   Sehgal Chandra M.   Fairman Ronald M.   Ky Bonnie  

Journal for Vascular Ultrasound, Vol. 39, Iss. 3, 2015-09 ,pp. : 127-132

Society for Vascular Ultrasound

Access to resources Recommend Favorite

Effect of Cilostazol, a Phosphodiesterase III Inhibitor, on Experimental Thrombosis in the Porcine Carotid Artery - Effects of ticlopidine

By Kohda N.   Tani T.   Nakayama S.   Adachi T.   Marukawa K.   Ito R.   Ishida K.   Matsumoto Y.   Kimura Y.  

Thrombosis Research, Vol. 96, Iss. 4, 1999-11 ,pp. : 261-268

Elsevier

Access to resources Recommend Favorite

Multifaceted Effects of Selective Inhibitor of Phosphodiesterase III, Cilostazol, for Cerebral Vasospasm after Subarachnoid Hemorrhage in a Dog Model

By  

Cerebrovascular Diseases, Vol. 28, Iss. 2, 2009-06 ,pp. : 135-142

Karger

Access to resources Recommend Favorite

Changes in the Fibrinolytic System in Patients with Peripheral Arterial Occlusive Disease Undergoing Percutaneous Transluminal Angioplasty - A potential progenitor of restenosis

By Roller R.E.   Janisch S.   Carroll V.   Kvas E.   Pilger E.   Binder B.R.   Wojta J.  

Thrombosis Research, Vol. 94, Iss. 4, 1999-05 ,pp. : 241-247

Elsevier

Access to resources Recommend Favorite

Novel Oral Anticoagulants in Peripheral Arterial and Coronary Artery Disease

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 21-25

Bentham Science Publishers

Access to resources Recommend Favorite